Suchergebnisse - "Zhang, Lele"

PubPharm (10)

1

The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Shen, Z. | Teng, M. | Han, L. | +10

2

The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer

enthalten in: Cancer immunology immunotherapy | 2023

von Shen, Z. | Teng, M. | Han, L. | +10

3

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

enthalten in: Genome medicine | 2023

von Hu, J. | Zhang, L. | Xia, H. | +17

CommentIn: Transl Lung Cancer Res. 2023 Aug 30;12(8):1807-1811. - PMID 37691874

4

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

enthalten in: Genome medicine | 2023

von Hu, J. | Zhang, L. | Xia, H. | +17

5

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

enthalten in: Genome medicine | 2023

von Hu, J. | Zhang, L. | Xia, H. | +17

6

Blood-based tumour mutation index act as prognostic predictor for immunotherapy and chemotherapy in non-small cell lung cancer patients

enthalten in: Biomarker research | 2022

von Lu, J. | Wu, J. | Lou, Y. | +14

7

Blood-based tumour mutation index act as prognostic predictor for immunotherapy and chemotherapy in non-small cell lung cancer patients

enthalten in: Biomarker Research | 2022

von Lu, J. | Wu, J. | Lou, Y. | +14

8

Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China

enthalten in: Clinical lung cancer | 2020

von Zhao, Y. | Dong, Y. | Zhao, R. | +7

9

Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2018

von Wang, S. | Zhang, B. | Qian, J. | +8

10

Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients : First or third generation tyrosine kinase inhibitors (TKIs)?

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2018

von Zhang, B. | Xu, J. | Zhang, X. | +12

1
[1]